Utilizing clinical trials to demonstrate clinical efficacy has been a mainstay within the therapeutic industry for years. However, with the introduction of new digital interventions, these trials are no longer efficient and optimal. This panel, led by the industry experts, will dive into the intricacies of adapting clinical trials specifically for digital therapeutics
- What are the challenges with current clinical trials for digital therapeutics?
- Where can changes be made within the clinic to develop more efficient trials for DTx?
- An insight into decentralized clinical trials and why many digital therapeutics companies are adopting this as the new normal
- How do decentralized clinical trials compare to traditional studies?
- What is the future of clinical trials for digital health interventions?
